AGIOS PHARMACEUTICALS, INC. Annual Income Tax Expense (Benefit) in USD from 2011 to 2019

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary: Agios Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2011 to 2019.
Agios Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $53.1M.
Agios Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2019 was $0.000.
Agios Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2018 was $0.000.
Agios Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2017 was $0.000.

Income Tax Expense (Benefit), Trailing 12 Months (USD)

Income Tax Expense (Benefit), Annual (USD)

Income Tax Expense (Benefit), YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2019	$0	$0		Jan 1, 2019	Dec 31, 2019	10-K	2020-02-19
2018	$0	$0		Jan 1, 2018	Dec 31, 2018	10-K	2020-02-19
2017	$0	$0		Jan 1, 2017	Dec 31, 2017	10-K	2020-02-19
2016	$0	$0		Jan 1, 2016	Dec 31, 2016	10-K	2019-02-14
2015	$0	+$426K		Jan 1, 2015	Dec 31, 2015	10-K	2018-02-14
2014	-$426K	-$1.01M	-174%	Jan 1, 2014	Dec 31, 2014	10-K	2017-02-16
2013	$579K	+$3.4M		Jan 1, 2013	Dec 31, 2013	10-K	2016-02-26
2012	-$2.82M	-$10M	-139%	Jan 1, 2012	Dec 31, 2012	10-K	2015-02-24
2011	$7.21M			Jan 1, 2011	Dec 31, 2011	10-K	2014-03-18

* An asterisk sign (*) next to the value indicates that the value is likely invalid.